Terms: = Sarcomas AND TIMP1, CLGI, EPA, EPO, HCI, TIMP, TIMP-1 AND Prognosis
16 results:
1. miR-1293 suppresses osteosarcoma progression by modulating drug sensitivity in response to cisplatin treatment.
Wang T; Huang J; Chen G; Fu J; Li T; Zou X; Yi H
Int Immunopharmacol; 2024 Mar; 130():111702. PubMed ID: 38367464
[TBL] [Abstract] [Full Text] [Related]
2. FTIR Microspectroscopy as a new probe to study human uterine lesions: Characterization of tumor cell lines from uterine smooth muscle cells and evaluation of epa and DHA in vitro treatments.
Belloni A; Notarstefano V; Greco S; Pellegrino P; Giorgini E; Ciarmela P
Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166873. PubMed ID: 37666437
[TBL] [Abstract] [Full Text] [Related]
3. A prospective cohort study of timp1 as prognostic biomarker in gastric and colon cancer.
Macedo FC; Cunha N; Pereira TC; Soares RF; Monteiro AR; Bonito N; Valido F; Sousa G
Chin Clin Oncol; 2022 Dec; 11(6):43. PubMed ID: 36509552
[TBL] [Abstract] [Full Text] [Related]
4. Identification and Functional Analysis of epoR
Li Y; Li M; Wei R; Wu J
J Immunol Res; 2020; 2020():9374240. PubMed ID: 32908942
[TBL] [Abstract] [Full Text] [Related]
5. The transition of tissue inhibitor of metalloproteinases from -4 to -1 induces aggressive behavior and poor patient survival in dedifferentiated liposarcoma via YAP/TAZ activation.
Shrestha M; Ando T; Chea C; Sakamoto S; Nishisaka T; Ogawa I; Miyauchi M; Takata T
Carcinogenesis; 2019 Oct; 40(10):1288-1297. PubMed ID: 31074490
[TBL] [Abstract] [Full Text] [Related]
6. Elevated ratio of MMP2/MMP9 activity is associated with poor response to chemotherapy in osteosarcoma.
Kunz P; Sähr H; Lehner B; Fischer C; Seebach E; Fellenberg J
BMC Cancer; 2016 Mar; 16():223. PubMed ID: 26979530
[TBL] [Abstract] [Full Text] [Related]
7. Serum markers in early-stage and locally advanced melanoma.
Lugowska I; Kowalska M; Fuksiewicz M; Kotowicz B; Mierzejewska E; Koseła-Paterczyk H; Szamotulska K; Rutkowski P
Tumour Biol; 2015 Nov; 36(11):8277-85. PubMed ID: 26002577
[TBL] [Abstract] [Full Text] [Related]
8. Expression of matrix metalloproteinases-2, -8, -13, -26, and tissue inhibitors of metalloproteinase-1 in human osteosarcoma.
Korpi JT; Hagström J; Lehtonen N; Parkkinen J; Sorsa T; Salo T; Laitinen M
Surg Oncol; 2011 Mar; 20(1):e18-22. PubMed ID: 20880700
[TBL] [Abstract] [Full Text] [Related]
9. Analysis of HIF-1a and its regulator, PHD2, in retroperitoneal sarcomas: clinico-pathologic implications.
Huang JH; Lee FS; Pasha TL; Sammel MD; Karakousis G; Xu G; Fraker D; Zhang PJ
Cancer Biol Ther; 2010 Feb; 9(4):303-11. PubMed ID: 20026900
[TBL] [Abstract] [Full Text] [Related]
10. Establishment of a nude mouse transplantable model of a human malignant fibrous histiocytoma of the mandible with high metastatic potential to the lung.
Maeda T; Hashitani S; Zushi Y; Segawa E; Tanaka N; Sakurai K; Urade M
J Cancer Res Clin Oncol; 2008 Sep; 134(9):1005-11. PubMed ID: 18317806
[TBL] [Abstract] [Full Text] [Related]
11. [Correlation between matrix metalloproteinases-2 and tissue inhibitor of metalloproteinase-2 expression, metastatic potential and tumor angiogenesis in synovial sarcoma and its prognostic significance].
Sun BC; Sun Y; Zhao XL; Wang J; Wang X; Liu YX
Zhonghua Bing Li Xue Za Zhi; 2006 Mar; 35(3):155-8. PubMed ID: 16630504
[TBL] [Abstract] [Full Text] [Related]
12. Increased expression of membrane-type matrix metalloproteinase-1 is correlated with poor prognosis in patients with osteosarcoma.
Uchibori M; Nishida Y; Nagasaka T; Yamada Y; Nakanishi K; Ishiguro N
Int J Oncol; 2006 Jan; 28(1):33-42. PubMed ID: 16327977
[TBL] [Abstract] [Full Text] [Related]
13. Correlation between the histological grade of chondrosarcoma and the expression of MMPs, ADAMTSs and timps.
Sugita H; Osaka S; Toriyama M; Osaka E; Yoshida Y; Ryu J; Sano M; Sugitani M; Nemoto N
Anticancer Res; 2004; 24(6):4079-84. PubMed ID: 15736455
[TBL] [Abstract] [Full Text] [Related]
14. Tissue and serum loss of metalloproteinase inhibitors in high grade soft tissue sarcomas.
Benassi MS; Magagnoli G; Ponticelli F; Pazzaglia L; Zanella L; Gamberi G; Ragazzini P; Ferrari C; Mercuri M; Picci P
Histol Histopathol; 2003 Oct; 18(4):1035-40. PubMed ID: 12973672
[TBL] [Abstract] [Full Text] [Related]
15. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease.
Strongin AY; Collier I; Bannikov G; Marmer BL; Grant GA; Goldberg GI
J Biol Chem; 1995 Mar; 270(10):5331-8. PubMed ID: 7890645
[TBL] [Abstract] [Full Text] [Related]
16. Sarcomatoid renal cell carcinoma. A treatable entity.
Sella A; Logothetis CJ; Ro JY; Swanson DA; Samuels ML
Cancer; 1987 Sep; 60(6):1313-8. PubMed ID: 2441841
[TBL] [Abstract] [Full Text] [Related]
